SCHEMBL8963667

SCHEMBL8963667

Cc1[nH]cnc1CN1CCN(C(c2ccccc2)c2ccccc2)CC1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CD44 P16070 2/20 0.54
OPRD1 P41143 2/20 0.51
CYP3A4 P08684 3/20 0.49
CYP2C19 P33261 2/20 0.49
CYP2C9 P11712 1/20 0.49
ATM Q13315 2/20 0.49
LMNA P02545 3/20 0.48
NPSR1 Q6W5P4 2/20 0.48
HTT P42858 1/20 0.48
P2RX7 Q99572 1/20 0.47
MEN1 O00255 4/20 0.47
KMT2A Q03164 4/20 0.47
OPRM1 P35372 2/20 0.46
USP2 O75604 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2D6 P10635 1/20 0.46
HPN P05981 1/20 0.46
CHRM2 P08172 1/20 0.46
ADRA2A P08913 1/20 0.46
ADORA3 P0DMS8 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8963684 0.79 CYP3A4 (0.49) OPRD1CYP3A4CYP2C19CYP2C9ATM
SCHEMBL8963668 0.76 DRD2 (0.64) OPRD1CYP3A4CYP2C19CYP2C9ATM
SCHEMBL9424756 0.76 LMNA (0.47) OPRD1LMNANPSR1HTTMEN1
SCHEMBL8963705 0.75 LMNA (0.52) OPRD1CYP3A4CYP2C19CYP2C9ATM
SCHEMBL16227069 0.75 KMT2A (0.61) OPRD1CYP3A4CYP2C19CYP2C9ATM
SCHEMBL8963605 0.74 CYP3A4 (0.45) CYP3A4CYP2C19CYP2C9ATMLMNA
SCHEMBL10617846 0.74 CD44 (0.56) CD44CYP3A4CYP2C19CYP1A2ADRA2C
SCHEMBL8963541 0.73 DRD2 (0.49) CYP3A4CYP2C19CYP2C9ATMLMNA
Lifarizine SCHEMBL676318 0.73 DRD2 (0.57) CYP3A4CYP2C19CYP2C9ATMLMNA
SCHEMBL9720665 0.73 ATM (0.51) OPRD1ATMLMNANPSR1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5514800-A CALCIUM CHANNEL BLOCKERS, CEREBRAL ISCHEMIA SYNTEX PHARMACEUTICALS, LTD. (GB) 1996-05-07 US disclosed
US-5276034-A Cardiovascular disorders, nervous system disorders, diuretics, antiischemic agents or antispasmodic agents SYNTEX PHARMACEUTICAL LTD. (GB) 1994-01-04 US disclosed
US-5252736-A Calcium channel antagonists SYNTEX PHARMACEUTICALS, LTD. (GB) 1993-10-12 US disclosed
US-5091428-A Calcium channel blockers preferential for cerebral blood vessels SYNTEX PHARMACEUTICALS, LTD. (BM) 1992-02-25 US disclosed
US-5043447-A Substituted imidazolyl-alkyl-piperazine and -diazepine derivatives SYNTEX PHARMACEUTICALS, LTD. (GB) 1991-08-27 US disclosed
US-5010075-A Antiepilepic, hypotensive, antiarrhythmia, antiischemic agent SYNTEX PHARMACEUTICALS LTD. (GB) 1991-04-23 US disclosed
US-4935417-A CALCIUM CHANNEL BLOCKERS SYNTEX PHARMACEUTICALS LTD. (BM) 1990-06-19 US disclosed
US-4829065-A Substituted imidazolyl-alkyl-piperazine and -diazepine derivatives SYNTEX PHARMACEUTICALS, LTD. (GB) 1989-05-09 US disclosed